New Jersey now has more than 80 data centers, many clustered near Manhattan. Critics worry about their potential to hike ...

The pharmaceutical company’s success developing medicines for obesity has swelled its worth to levels associated with tech titans like Apple and Google and dwarfed that of its drugmaking peers.

In spring 2026, Patrick Vandenameele will succeed Luc Van den hove as CEO of imec. In an interview with Markt & Technik, he ...

Discover how Abselion’s Amperia™ platform delivers fast, reproducible His-tagged protein quantification with minimal prep, even from crude lysates.

His love of cycling dates to his time as a student competing in ’s famed Little 500 bicycle race, where Lewis was part of the ...

Just 10 years ago, there was virtually no biopharmaceutical industry in China. But now, almost all global big pharma ...

Citi Annual Global Healthcare Conference 2025 December 2, 2025 11:15 AM ESTCompany ParticipantsAndrew Dickinson - ...

Strong clinical data doesn’t just move share prices – it can unlock lucrative global licensing deals for ASX-listed healthcare companies.

Merck & Co. is spending $9.2 billion for Cidara Therapeutics and its lead influenza antiviral that was dropped by Johnson & Johnson last year. Merck is paying $221.50 cash per share of Cidara, a San ...

Nov 14 (Reuters) - Merck (MRK.N), opens new tab will acquire Cidara Therapeutics (CDTX.O), opens new tab in a nearly $9.2 billion deal, gaining access to an experimental flu drug in its effort to ...

Nov 17 (Reuters) - Merck (MRK.N), opens new tab said on Monday it expects a commercial opportunity exceeding $5 billion from Cidara Therapeutics' (CDTX.O), opens new tab experimental flu drug, and ...